In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OvaMed

Executive Summary

OvaMed is making a full line of outpatient catheters for gynecologists.

Business:Catheters

111 W. Evelyn, Suite 214, Sunnyvale, CA 94086
(408) 720-9876
Contact:John N. Zink, president & CEO
Founded:April 1991

Manufacturing a full line of outpatient catheters for gynecologists. OvaMed Corp.’s GyneSysSystem designed to perform tubal cannulation. GyneSys System’s three catheters work sequentially to diagnose and treat the uterus and fallopian tubes. Use of the GyneSys on an outpatient basis can reduce health care costs and expedite treatment of suspected infertility. Product now approved in Europe.

Additional products also designed to allow many hospital procedures to be performed in physicians’ offices. GynePathbiopsy needles acquire hist-ological specimens of tissue. Can be used for lesions in the breast, uterus and abdomen using ultrasound or CT. OvaMed’s falloposcope and hysteroscope enhance diagnoses during patient visits.

OvaCathtransfer catheter used to treat tubal ectopics, trans-vaginal GIFT and other procedures. New products in development designed to treat ovarian cysts, uterine leiomyomas and to ablate the endometrium non-surgically.

Venture funding from Vanguard Associates III, Venture Fund of Washington, Tredegar Investments, J&J Develpment Corp. and Investment Advisors. President and CEO John N. Zink previously held senior positions at Diasonics, Criticare, Paramed and Beckman.—WL

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

IV000015

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel